Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Restoring synapse integrity and memory in Alzheimer’s disease by downregulation of the Wnt antagonist Dickkopf-3

Martin-Flores, Nuria, Podpolny, Marina, McLeod, Faye, Crawford, Karen, Ivanov, Dobril ORCID: https://orcid.org/0000-0001-6271-6301, Escott-Price, Valentina ORCID: https://orcid.org/0000-0003-1784-5483 and Salinas, Patricia 2022. Restoring synapse integrity and memory in Alzheimer’s disease by downregulation of the Wnt antagonist Dickkopf-3. [Online]. bioRxiv: bioRxiv. Available at: https://www.biorxiv.org/content/10.1101/2022.06.16...

[thumbnail of 2022.06.16.495307v1.full.pdf] PDF - Submitted Pre-Print Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (9MB)

Abstract

Increasing evidence supports a role of deficient Wnt signaling in Alzheimer’s disease (AD). Recent studies reveal that the secreted Wnt antagonist Dickkopf-3 (DKK3) is elevated in the human AD brain. Here, we investigate the contribution of DKK3 to synapse integrity in the healthy and AD brain. We uncover a novel genetic link between DKK3 gene variants and AD risk. Our findings show that DKK3 protein is increased in different human brain fractions consistent with disease progression. In the hAPP-J20 and hAPPNL-G-F/NL-G-F AD models, DKK3 accumulates at plaques in the brain. Oligomers of amyloid-β enhance the secretion of DKK3 from cultured neurons and DKK3 secretion is also increased in hippocampal slices of hAPP-J20 mice. In addition, gain-of-function experiments revealed that DKK3 decreases the density of excitatory synapses through inhibition of the canonical Wnt/GSK3β pathway but increases inhibitory synapse density through activation of the Wnt/JNK pathway. Our studies demonstrate that in vivo DKK3 downregulation restores synapse number in hAPP-J20 mice. Importantly, DKK3 knockdown improves memory in this AD model. Collectively, our findings identify DKK3 as a novel driver of synapse defects and memory impairment in AD.

Item Type: Website Content
Date Type: Publication
Status: Published
Schools: Medicine
Publisher: bioRxiv
Date of Acceptance: 17 June 2022
Last Modified: 10 Feb 2024 02:15
URI: https://orca.cardiff.ac.uk/id/eprint/154024

Actions (repository staff only)

Edit Item Edit Item

Downloads

Downloads per month over past year

View more statistics